$SBS

Szlak Daniel sold $209K of SBS

Szlak Daniel (Chief Financial Officer) sold 7,381 shares of COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP (SBS) at $28.30 ($0.21M total) across 2 trades on 2026-06-15.

Original reporting
SEC EDGAR · Szlak Daniel
Published Jun 16, 2026, 8:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SBS
Neutral
high confidence
Mentioned
$SBS
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SBSNeutralLow
01

Why it matters

This is a disclosed ownership change by an officer. It can influence short-term sentiment, but it does not introduce new information about SABESP’s business, financial results, or outlook.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without additional company catalysts.

03

What to watch

The article shows the CFO ended with 0 shares, but it does not provide context (taxes, exercise/vesting, diversification) or any concurrent company fundamentals.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-16; sale executed 2026-06-15.

Background

The article is a SEC Form 4 insider transaction: CFO Szlak Daniel sold 7,381 shares of SABESP (SBS) at $28.30 on 2026-06-15.

Company-level read

Ticker impact

$SBSNeutralHigh confidence
Context

SABESP CFO Szlak Daniel sold $208,882 of SBS shares via two open-market trades at $28.30 on 2026-06-15.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing is an officer open-market sale with no 10b5-1 plan stated and no accompanying company news (earnings, guidance, contracts, enforcement).

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated; transaction is for the issuer’s own shares.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; without a 10b5-1 plan, the signal is still typically weak absent other disclosures.

Key entities

  • COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO-SABESP

    Issuer of the securities involved in the insider sale (SBS).

  • Szlak Daniel

    Chief Financial Officer who sold shares via open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles